Apoptotic efficacy and inhibitory effect of dexamethasone on matrix metalloproteinase

Medical Science Monitor

Volumn 11, Issue 7, 2005, Pages

  Saadat, Farshid ^a   Khorramizadeh, Mohammad Reza ^a   Mirshafiey, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Cancer; Dexamethasone; Matrix metalloproteinases

Indexed keywords

DEXAMETHASONE; DICLOFENAC; GELATINASE A; MATRIX METALLOPROTEINASE; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME INHIBITION; FIBROSARCOMA; INFLAMMATION; MOUSE; NICK END LABELING; NONHUMAN; ZYMOGRAPHY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DEXAMETHASONE; DICLOFENAC; FIBROSARCOMA; HUMANS; IN SITU NICK-END LABELING; MATRIX METALLOPROTEINASE 2; PIROXICAM;

EID: 22244463254     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Barnes PJ, Adcock I: Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci, 1993; 14: 436-41
2. Ichiyoshi H, Kiyozuka Y, Kishimoto Y: Massive telomere loss and telomerase RNA expression in dexamethasone-induced apoptosis in mouse thymocytes. Exp MoI Pathol, 2003; 75: 178-86
3. Amsterdam A, Sasson R: The anti-inflammatory action of glucocorticoids is mediated by cell type specific regulation of apoptosis. Mol Cell Endocrinol, 2002: 189, 1-9
4. Wen LP, Madani K, Fahrni JA et al: Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-gamma and Fas. Am J Physiol, 1997; 273: 921-29
5. Kato T, Takeda Y, Nakada T, Sendo F: Inhibition by dexamethasone of human neutrophil apoptosis in vitro. Nat Immun, 1995; 14: 198-208
6. Yamamoto M, Fukuda K, Miura N et al: Inhibition by dexamethasone of transforming growth factor betal-induced apoptosis in rat hepatoma cells: a possible association with Bcl-xL induction. Hepatology, 1998; 27: 959-66
7. Messmer UK, Winkel G, Briner VA, Pfeilschifter J: Suppression of apoptosis by glucocorticoids in glomerular endothelial cells: effects on proapoptotic pathways. Br J Pharmacol, 2000; 129: 1673-83
8. Yang-Yen H F, Chambard J C, Sun Y L et al: Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell, 1990; 62: 1205-15
9. Pelletier JP, Cloutier JM, Martel-Pelletier J: In vitro effects of tiaprofenic acid, sodium salicylate and hydrocortisone on the proteoglycan metabolism of human osteoarthritic cartilage. J Rheumatol, 1989; 16: 646-55
10. Farquhar T, Todhunter RJ, Fubini SL et al: Effect of methylprednisolone and mechanical loading on canine articular cartilage in explant culture. Osteoarthritis Cartilage, 1996; 4: 55-62
11. Nakamura M, Watanabe J, Ogawa R, Kanamura S: Immunohistochemical localization of type II and type I collagens in articular cartilage of the femoral head of dexamethasone-treated rats. Histochem J, 1997; 29: 645-54
12. MacLeod JN, Fubini SL, Gu DN et al: Effect of synovitis and corticosteroids on transcription of cartilage matrix proteins. Am J Vet Res, 1998; 59: 1021-26
13. Stetler-Stevenson WG, Hewitt R, Corcoran M: Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol, 1996; 7: 147-54
14. Jones L, Ghaneh P, Humphreys M, Neoptolemos JP: The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer. Ann New York Acad Sci 1999, 880, 288-307.
15. John A, Tuszynski G: The role of matrix metalloproteinase in tumor angiogenesis and tumor metastasis. Pathol Oncol Res, 2001; 7: 14-23
16. Nguyen M, Arkell J, Jackson CJ: Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol, 2001; 33: 960-70
17. Heussen C, Dowdle EB: Electrophoretic analysis of plasminogen activator in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem, 1980; 102: 196-202
18. Cohen JJ: Glucocorticoid-induced apoptosis in the thymus. Semin Immunol, 1992; 4: 363-69
19. Kudawara I, Ueda T, Yoshikawa H et al: In vivo inhibition of tumour growth by dexamethasone in murine osteosarcomas. Eur J Cancer, 2001; 37: 1703-708
20. Bel'skaya NV, Stal'bovskaya ES, Bel'skii YP, Agafonov VI: Opposite effects of dexamethasone on antitumor and natural suppressor activities of bone marrow cells. Bull Exp Biol Med, 2000; 129: 386-88
21. Bernardi RJ, Trump DL, Yu WD et al: Combination of alpha,25- dihydroxyvitamin D (3) with dexamethasone enhances cell cycle arrest and apoptosis: role of nuclear receptor cross-talk and Erk/Akt signaling. Clin Cancer Res, 2001; 7: 4164-73
22. Valencia AM, Beharry KD, Ang JG et al: Early postnatal dexamethasone influences matrix metalloproteinase-2 and -9, and their tissue inhibitors in the developing rat lung. Pediatr Pulmonol, 2003; 35: 456-62
23. Stove J, Schoniger R, Huch K et al: Effects of dexamethasone on proteoglycan content and gene expression of IL-1 beta-stimulated osteoarthritic chondrocytes in vitro. Acta Orthop Scand, 2002; 73: 562-67
24. Tome ME, Lutz NW, Briehl MM: Overexpression of catalase or Bcl-2 delays or prevents alterations in phospholipid metabolism during glucocorticoid-induced apoptosis in WEHI7.2 cells. Biochim Biophys Acta, 2003; 1642: 149-62
25. Wong MW, Tang YY, Lee SK et al: Effect of dexamethasone on cultured human tenocytes and its reversibility by platelet-derived growth factor. J Bone Joint Surg Am, 2003; 10: 1914-20
26. Yamamoto T, Nishiguchi M, Inoue N et al: Inhibition of murine osteosarcoma cell proliferation by glucocorticoid. Anticancer Res, 2002; 22: 4151-56
27. Sasson R, Tajima K, Amsterdam A: Glucocorticoids protect against apoptosis induced by serum deprivation, cyclic adenosine 30, 50-monophosphate and p53 activation in immortalized human granulosa cells: involvement of Bcl-2. Endocrinology, 2001; 142: 802-11
28. Pross C, Farooq MM, Angle N et al: Dexamethasone inhibits vascular smooth muscle cell migration via modulation of matrix metalloproteinase activity. J Surg Res, 2002; 102: 57-62